Decreased serum growth differentiation factor 15 levels after lifestyle intervention in patients with newly diagnosed type 2 diabetes mellitus
نویسندگان
چکیده
Recent studies noted that circulating growth differentiation factor 15 (GDF15) were closely related to metabolic states. Moreover, lifestyle intervention (LI) contributed improvements among patients with diabetes. The study aimed explore the changes of GDF15 levels and their influencing factors after 4 weeks LI or combined breakfast meal replacement (LI + MR) in newly diagnosed type 2 diabetes patients. A total 84 available serum samples at both baseline Week-4 enrolled this biomarker substudy. All subjects underwent a 2-h 75 g oral glucose tolerance test Week-4. Serum determined by sandwich enzyme-linked immunosorbent assay. After LI, overall significantly decreased compared (P < 0.05). ΔGDF15 negatively associated (r = −0.450, P 0.001). optimal cut-off point for predicting decrease was 904.57 pg/mL, an area under curve 0.699. Based on 900 ≥ pg/mL had while those <900 no significant changes. Regression models showed level independent positive improvement fasting plasma homeostasis model assessment insulin resistance only ≥900 pg/mL. led its effect more
منابع مشابه
Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
We investigated an association between serum Growth Differentiation Factor 15 (GDF15) level and cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus (T2D). A total of 107 participants were screened for T2D and divided into a T2D group and a control group (without diabetes). We used the Framingham risk score (FRS) and the New Pooled Cohort Equation score to estimate the ...
متن کاملEffect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus
Background: There is growing evidence that diabetes mellitus (DM) is an important risk factor for tuberculosis (TB). A significant number of DM patients have poor glycemic control. This study was carried out to find the impact of poor glycemic control on newly diagnosed smear-positive pulmonary tuberculosis patients with type-2 diabetes mellitus in a tertiary care hospital.Methods: In a hospita...
متن کاملElevated Interleukin-17 Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Interleukin (IL)-17 is a newly described T cell-derived inflammatory cytokine. Recent studies have shown that inflammatory cytokines play important roles in the pathogenesis of type 2 diabetes mellitus (DM). However, whether IL-17 plays a prominent role in type 2 DM remains unclear. Here we measured serum concentrations of IL-17, and mRNA expression of IL-17 and its transcription factor RORγt i...
متن کاملIncreased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus
BACKGROUND MicroRNAs (miRNAs), a class of small non-coding RNAs, are thought to serve as crucial regulators of gene expression. Dysregulated expression of miRNAs has been described in various diseases and may contribute to related pathologic processes. Our aim was to examine circulating miRNA-146a levels in newly diagnosed type 2 diabetes mellitus (new-T2DM) patients from a Chinese Han populati...
متن کاملElevated plasma levels of SPARC in patients with newly diagnosed type 2 diabetes mellitus.
OBJECTIVE Secreted protein acidic and rich in cysteine (SPARC) also known as BM-40 which has been studied in various pathological conditions, has recently been suggested as a key player in the pathology of obesity and type 2 diabetes mellitus (T2DM). However, there are few studies on putative pathophysiologic roles of SPARC in glucose metabolism. The aim of this study was to determine whether p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obesity Medicine
سال: 2021
ISSN: ['2451-8476']
DOI: https://doi.org/10.1016/j.obmed.2021.100345